Jena, April 30, 2026. Analytik Jena AG is launching the “PULSEspencer” series, a new technology for the contactless dispensing of the smallest liquid quantities. The official presentation will take place in May at the SLAS Europe trade fair in Wien.
- Company: Analytik Jena AG
- Product: PULSEspencer series (laboratory automation)
- Function: Contactless dispensing in the picoliter range
- Presentation: May 2026 at SLAS Europe in Wien
- Application areas: Drug research, gene analysis, cell research
More precise and economical laboratory processes
With the new PULSEspencer series, the Jena-based technology company is responding to the growing demands of modern laboratory work. The development focuses on the ability to dispense samples and reagents contactlessly and in extremely small quantities – down to the so-called picoliter range. One picoliter corresponds to one trillionth of a liter. This extremely high precision significantly reduces material consumption in laboratories. At the same time, the absence of direct physical contact reduces the risk of contamination of sensitive samples.
Focus on international orientation
The technology is specifically designed for highly innovative sectors such as drug research, gene analysis, and cell research, where speed and purity are top priorities. With the market launch and the upcoming presentation at the SLAS Europe trade fair in Wien, Analytik Jena AG aims to strategically expand its position in the competitive international market for laboratory automation.
Background: Analytik Jena and the optics location
Analytik Jena AG, originally founded in 1990, is one of the central players in the traditional optics and photonics location of Jena. The city on the Saale has been considered a European center for high technology, precision mechanics, and optical instruments since the historical work of Carl Zeiss, Otto Schott, and Ernst Abbe in the 19th century. Today, laboratory automation is a crucial and global growth market. Worldwide, laboratories are upgrading to faster, automated high-throughput screenings (High-Throughput Screening) to save massive amounts of time and costs in the development of new drugs, therapies, or vaccines, for example. Techniques capable of processing droplets in the picoliter range are the key to a more efficient medical future.
Source:
Analytik Jena launches new laboratory technology on the market
Transparency note: This article was created automatically, editorially reviewed, and expanded with AI support.